Wall Street Access Asset Management, LLC Amgen Inc Transaction History

Wall Street Access Asset Management, LLC

  • $248 Million
  • Q1 2025

A detailed history of Wall Street Access Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wall Street Access Asset Management, LLC holds 2,586 shares of AMGN stock, worth $792,815. This represents 0.32% of its overall portfolio holdings.

Number of Shares
2,586
Previous 2,472 4.61%
Holding current value
$792,815
Previous $644,000 25.0%
% of portfolio
0.32%
Previous 0.24%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$258.59 - $327.36 $29,479 - $37,319
114 Added 4.61%
2,586 $805,000
Q4 2024

Jan 17, 2025
BUY
$258.78 - $328.31 $11,127 - $14,117
43 Added 1.77%
2,472 $644,000
Q3 2024

Nov 08, 2024
BUY
$309.38 - $337.38 $4,021 - $4,385
13 Added 0.54%
2,429 $782,000
Q2 2024

Jul 29, 2024
BUY
$262.75 - $319.31 $68,052 - $82,701
259 Added 12.01%
2,416 $754,000
Q1 2024

May 09, 2024
BUY
$268.87 - $324.56 $2,688 - $3,245
10 Added 0.47%
2,157 $613,000
Q4 2023

Apr 25, 2024
SELL
$255.7 - $288.46 $37,843 - $42,692
-148 Reduced 6.45%
2,147 $618,000
Q4 2023

Feb 13, 2024
SELL
$255.7 - $288.46 $37,843 - $42,692
-148 Reduced 6.45%
2,147 $618,000
Q3 2023

Apr 25, 2024
SELL
$218.65 - $271.46 $190,006 - $235,898
-869 Reduced 27.47%
2,295 $616,000
Q3 2023

Nov 06, 2023
SELL
$218.65 - $271.46 $190,006 - $235,898
-869 Reduced 27.47%
2,295 $616,000
Q2 2023

Apr 25, 2024
BUY
$214.27 - $253.37 $2,785 - $3,293
13 Added 0.41%
3,164 $702,000
Q2 2023

Aug 10, 2023
BUY
$214.27 - $253.37 $2,785 - $3,293
13 Added 0.41%
3,164 $702,000
Q1 2023

Apr 25, 2024
BUY
$225.79 - $275.2 $225 - $275
1 Added 0.03%
3,151 $761,000
Q1 2023

May 11, 2023
BUY
$225.79 - $275.2 $225 - $275
1 Added 0.03%
3,151 $761,000
Q4 2022

Apr 25, 2024
BUY
$229.03 - $291.01 $229,717 - $291,883
1,003 Added 46.72%
3,150 $827,000
Q4 2022

Feb 02, 2023
BUY
$229.03 - $291.01 $2,061 - $2,619
9 Added 0.29%
3,150 $827,000
Q3 2022

Nov 14, 2022
BUY
$224.46 - $253.15 $1,346 - $1,518
6 Added 0.19%
3,141 $708,000
Q2 2022

Aug 15, 2022
BUY
$230.71 - $256.74 $1,614 - $1,797
7 Added 0.22%
3,135 $762,000
Q1 2022

May 16, 2022
BUY
$219.27 - $242.57 $58,983 - $65,251
269 Added 9.41%
3,128 $756,000
Q4 2021

Feb 15, 2022
SELL
$198.88 - $227.6 $406,311 - $464,986
-2,043 Reduced 41.68%
2,859 $643,000
Q3 2021

Nov 15, 2021
BUY
$212.27 - $248.7 $435,790 - $510,581
2,053 Added 72.06%
4,902 $1.04 Million
Q2 2021

Aug 16, 2021
BUY
$233.58 - $259.14 $1,167 - $1,295
5 Added 0.18%
2,849 $694,000
Q1 2021

May 13, 2021
BUY
$221.91 - $258.6 $665 - $775
3 Added 0.11%
2,844 $707,000
Q4 2020

Feb 12, 2021
SELL
$216.38 - $257.67 $48,252 - $57,460
-223 Reduced 7.28%
2,841 $652,000
Q3 2020

Nov 13, 2020
BUY
$234.65 - $260.95 $95,737 - $106,467
408 Added 15.36%
3,064 $779,000
Q2 2020

Nov 02, 2021
SELL
$197.81 - $242.74 $79,321 - $97,338
-401 Reduced 13.12%
2,656 $627,000
Q1 2020

May 14, 2020
BUY
$182.24 - $241.7 $41,186 - $54,624
226 Added 7.98%
3,057 $619,000
Q4 2019

Feb 14, 2020
SELL
$189.21 - $243.2 $6,054 - $7,782
-32 Reduced 1.12%
2,831 $682,000
Q3 2019

Nov 14, 2019
BUY
$174.11 - $208.62 $174 - $208
1 Added 0.03%
2,863 $554,000
Q2 2019

Aug 13, 2019
SELL
$166.7 - $195.41 $12,002 - $14,069
-72 Reduced 2.45%
2,862 $527,000
Q4 2018

Feb 15, 2019
BUY
$178.4 - $208.25 $30,684 - $35,819
172 Added 6.23%
2,934 $571,000
Q3 2018

Oct 11, 2018
SELL
$185.29 - $208.89 $55,587 - $62,666
-300 Reduced 9.8%
2,762 $572,000
Q2 2018

Aug 13, 2018
BUY
$166.05 - $186.51 $22,084 - $24,805
133 Added 4.54%
3,062 $541,000
Q1 2018

May 15, 2018
BUY
$169.43 - $198.0 $26,431 - $30,888
156 Added 5.63%
2,929 $499,000
Q3 2017

Nov 15, 2017
BUY
$167.29 - $191.0 $463,895 - $529,643
2,773
2,773 $517,000

Others Institutions Holding AMGN

# of Institutions
3,285
Shares Held
426M
Call Options Held
8.07M
Put Options Held
7.7M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $164B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wall Street Access Asset Management, LLC Portfolio

Follow Wall Street Access Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wall Street Access Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wall Street Access Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email